Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0318377 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Kazuma Nagata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Oxygen, Pulmonary Alveoli, Respiratory Insufficiency. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science London, Ministry of Health, Labour and Welfare.
Themen: COPD
Abstract (Originalsprache)
Background
Chronic respiratory failure (CRF) is a critical complication in patients with chronic obstructive pulmonary disease (COPD) and is characterized by an increase in the arterial-alveolar oxygen gradient (A-aDO 2 ). The long-term trajectory and prognostic significance remain unclear. This study aimed to assess the prognostic impact of A-aDO 2 and elucidate its trajectory over ten years.
Methods
We enrolled 170 outpatients with COPD from a prospective cohort study. Arterial blood gas (ABG) analyses were conducted annually for ten years while monitoring the development of CRF.
Results
157 patients completed the observation period, of whom 21 developed CRF (CRF group) and 136 did not (non-CRF group). In the CRF group, there was a gradual increase in A-aDO 2 along with decreases in partial pressure of oxygen (PaO 2 ) and partial pressure of carbon dioxide (PaCO 2 ) over ten years, although there were no changes in the non-CRF group. The CRF group had higher baseline A-aDO 2 and higher ΔA-aDO 2 in the first year than the non-CRF group (3.76 vs. 0.42 Torr/year, p = 0.030). Kaplan-Meier analyses, and multivariate Cox proportional hazards analysis revealed that both baseline A-aDO 2 and ΔA-aDO 2 were significantly associated with the development of CRF. Retrospective tracking from the initiation of long-term oxygen therapy (LTOT) revealed significant increases in A-aDO 2 from 5 years prior to LTOT initiation in the CRF group when compared to the non-CRF group.
Conclusions
An increasing trend in A-aDO 2 may be a significant sign for the future development of CRF. A transition of the annual change of A-aDO 2 from a stable state to a deterioration phase can serve as a prognostic factor for developing CRF within 5 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
- Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
- Department of Respiratory Medicine, Nara Medical University, Kashihara, Nara, Japan.
ORCID-Profile: Susumu Sato, Toyohiro Hirai
Förderung
- Japan Society for the Promotion of Science London
- Ministry of Health, Labour and Welfare
Zitieren
APA
Nagata, K., Sato, S., Uemasu, K., Tanabe, N., Sato, A., Muro, S., & Hirai, T. (2025). Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade. PLOS ONE. https://doi.org/10.1371/journal.pone.0318377
Vancouver
Nagata K, Sato S, Uemasu K, Tanabe N, Sato A, Muro S, et al. Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade. PLOS ONE. 2025. doi:10.1371/journal.pone.0318377
BibTeX
@article{Nagata2025,
author = {Nagata, Kazuma and Sato, Susumu and Uemasu, Kiyoshi and Tanabe, Naoya and Sato, Atsuyasu and Muro, Shigeo and Hirai, Toyohiro},
title = {Trajectory of the arterial-alveolar oxygen gradient in COPD for a decade},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0318377}
}
EUVIMED